Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Notari

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Pharmacology & Therapeutics|January 1, 1981
Prodrug designR E Notari
Acta Pharmaceutica Suecica|December 1, 1975
Proceedings: Structural effects in pharmacokinetics and drug responseR E Notari
Methods in Enzymology|January 1, 1985
Theory and practice of prodrug kineticsR E Notari
Journal of Pharmaceutical Sciences|June 1, 1973
Pharmacokinetics and molecular modification: implications in drug design and evaluationR E Notari
Journal of Pharmaceutical Sciences|April 1, 1994
Cefuroxime hydrolysis kinetics and stability predictions in aqueous solutionD Wang, R E Notari
Journal of Pharmaceutical Sciences|February 1, 1972
Hydroxamic acids. IV. Hydroxide effect in hydroxylaminolysis of ethyl acetateR E Notari, T Baker
Biopharmaceutics & Drug Disposition|May 1, 1995
Methodology for using oral dose pharmacokinetic data to select drugs for prolonged release formulations and validation of the method using simulated dataM Zhou, R E Notari
Journal of Pharmaceutical Sciences|August 1, 1996
A nomogram to predict the best biological half-life values for candidates for oral prolonged-release formulationsM Zhou, R E Notari
Journal of Pharmaceutical Sciences|May 1, 1995
Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutionsM Zhou, R E Notari
Pharmaceutical Research|October 1, 1988
Potential improvement in shelf life using the prodrug approach. II. A systematic examination of kinetic requirementsN A Nguyen, R E Notari
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Pharmacology & Therapeutics|January 1, 1981
Prodrug designR E Notari
Acta Pharmaceutica Suecica|December 1, 1975
Proceedings: Structural effects in pharmacokinetics and drug responseR E Notari
Methods in Enzymology|January 1, 1985
Theory and practice of prodrug kineticsR E Notari
Journal of Pharmaceutical Sciences|June 1, 1973
Pharmacokinetics and molecular modification: implications in drug design and evaluationR E Notari
Journal of Pharmaceutical Sciences|April 1, 1994
Cefuroxime hydrolysis kinetics and stability predictions in aqueous solutionD Wang, R E Notari
Journal of Pharmaceutical Sciences|February 1, 1972
Hydroxamic acids. IV. Hydroxide effect in hydroxylaminolysis of ethyl acetateR E Notari, T Baker
Biopharmaceutics & Drug Disposition|May 1, 1995
Methodology for using oral dose pharmacokinetic data to select drugs for prolonged release formulations and validation of the method using simulated dataM Zhou, R E Notari
Journal of Pharmaceutical Sciences|August 1, 1996
A nomogram to predict the best biological half-life values for candidates for oral prolonged-release formulationsM Zhou, R E Notari
Journal of Pharmaceutical Sciences|May 1, 1995
Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutionsM Zhou, R E Notari
Pharmaceutical Research|October 1, 1988
Potential improvement in shelf life using the prodrug approach. II. A systematic examination of kinetic requirementsN A Nguyen, R E Notari
Pageof 5